9786202026475 - transdermal patch of an antihypertensive drug: transdermal patch di kumar yadav, pavan; kumar, deepak; pal, preeti (6 risultati)
- Brossura
Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 88,60
EUR 11,64 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: Brand New. 108 pages. 8.66x5.91x0.25 inches. In Stock.
- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 44,10
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Transdermal Patch of an Antihypertensive Drug | Transdermal Patch | Pavan Kumar Yadav (u. a.) | Taschenbuch | 108 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9786202026475 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot…]de | Anbieter: preigu.
- Brossura
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,90
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeri…c system by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio. 108 pp. Englisch.
- Brossura
- Print on Demand
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 41,71
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kumar Yadav Pavan1. Pawan kumar yadavDepartment of PharmacyM. J. P. Rohilkhand University, Bareilly (U.P.)2. Miss Preeti PalDepartment of PharmacyM. J. P. Rohilkhand University, Bareilly (U.P.)3. Deepa…k kumarDepartment of Applied Che.
- Brossura
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 49,90
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric sy…stem by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 108 pp. Englisch.
- Brossura
- Print on Demand
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 50,50
EUR 60,90 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The scenario of the research was to develop a polymer matrix diffusion controlled transdermal drug delivery system containing drug Telmisartan with different ratio of hydrophilic (HPMC) and lipophilic (EC, Eudragit RS 100) polymeric sys…tem by solvent casting technique on aluminum foil by using 30% w/v Dibutyl Phthalate of the polymeric weight, incorporated as plasticizer and 20% w/v, 30% w/v Dimethyl Sulfoxide( polymeric weight) was used to be permeation enhancer for transdermal drug release. Total Nine formulation developed by using same drug and different polymeric ratio. All transdermal patches were physicochemical evaluated with thickness, weight variation, % moisture uptake, % moisture loss, folding endurance, flatness, drug content and % drug release. . The invitro permeation study performed by diffusion cells. The maximum invitro % drug release was observed up to 48 hrs with formulation F8 containing HPMC: EC: Eudragit RS 100 in (5:0:1) ratio.
